Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | NCEH1 | Q6PIU2 | 2/20 | 0.37 |
| ▸ | CDC25A | P30304 | 1/20 | 0.36 |
| ▸ | CDC25B | P30305 | 1/20 | 0.36 |
| ▸ | CDC25C | P30307 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7542800 | 0.86 | ALDH1A1 (0.49) | ALDH1A1KMT2AMEN1HPGDMAPT | |
| SCHEMBL7539134 | 0.82 | KMT2A (0.53) | ALDH1A1KMT2AMEN1HPGDMAPT | |
| SCHEMBL7535988 | 0.80 | KMT2A (0.45) | ALDH1A1KMT2AMEN1HPGDMAPT | |
| SCHEMBL7535934 | 0.76 | SMN1; SMN2 (0.38) | ALDH1A1KMT2AMEN1HPGDMAPT | |
| SCHEMBL12426752 | 0.73 | NCEH1 (0.45) | ALDH1A1KMT2AMEN1HPGDMAPT | |
| SCHEMBL7191236 | 0.71 | ALDH1A1 (0.38) | ALDH1A1KMT2AHPGDMAPTGAA | |
| SCHEMBL1253157 | 0.70 | GAA (0.49) | ALDH1A1KMT2AMEN1HPGDMAPT | |
| SCHEMBL9485440 | 0.69 | GAA (0.47) | ALDH1A1HPGDMAPTCYP1A2CYP2C19 | |
| SCHEMBL7538616 | 0.69 | KMT2A (0.60) | ALDH1A1KMT2AMEN1HPGDMAPT | |
| SCHEMBL11250039 | 0.68 | L3MBTL1 (0.40) | ALDH1A1KMT2AMEN1HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | S.C. JOHNSON & SON, INC. | 2002-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | ACHE, DDT, GAP43 | ALDH1A1 1488/4885KMT2A 3439/4885MEN1 3828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.